How Teva CEO's Decision to List Shares Directly on NYSE Is Changing the Game The pharmaceutical giant's decision to bypass traditional IPOs has sent shockwaves through Wall Street.
Teva CEO Kåre Julin announced that shares will trade directly on the New York Stock Exchange (NYSE), marking a significant shift in how companies approach public listings.
The Science Behind Direct Listing on NYSE Direct listing allows companies to list their shares on an exchange without raising capital through a traditional initial public offering (IPO).